Neuronetics Capital Expenditures (CapEx) Growth & History (STIM)
Neuronetics's capital expenditures (capex) was $801,000 for fiscal 2025.
View full Neuronetics company overviewNeuronetics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $801,000 | −$665,000 | −45.36% |
| 2024 | 2024-12-31 | $1.5M | −$903,000 | −38.12% |
| 2023 | 2023-12-31 | $2.4M | −$900,000 | −27.53% |
| 2022 | 2022-12-31 | $3.3M | $916,000 | +38.93% |
| 2021 | 2021-12-31 | $2.4M | $1.6M | +222.33% |
| 2020 | 2020-12-31 | $730,000 | −$83,000 | −10.21% |
| 2019 | 2019-12-31 | $813,000 | −$198,000 | −19.58% |
| 2018 | 2018-12-31 | $1.0M | $417,000 | +70.20% |
| 2017 | 2017-12-31 | $594,000 | $270,000 | +83.33% |
| 2016 | 2016-12-31 | $324,000 | — | — |
Neuronetics quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $417,000 | $165,000 | +65.48% |
| Q1 2026 | 2026-03-31 | $197,000 | −$22,000 | −10.05% |
| Q4 2025 | 2025-12-31 | $216,000 | $127,000 | +142.70% |
| Q3 2025 | 2025-09-30 | $114,000 | −$272,000 | −70.47% |
| Q2 2025 | 2025-06-30 | $252,000 | −$364,000 | −59.09% |
| Q1 2025 | 2025-03-31 | $219,000 | −$156,000 | −41.60% |
| Q4 2024 | 2024-12-31 | $89,000 | −$790,000 | −89.87% |
| Q3 2024 | 2024-09-30 | $386,000 | −$166,000 | −30.07% |
| Q2 2024 | 2024-06-30 | $616,000 | −$88,000 | −12.50% |
| Q1 2024 | 2024-03-31 | $375,000 | $141,000 | +60.26% |
| Q4 2023 | 2023-12-31 | $879,000 | $376,000 | +74.75% |
| Q3 2023 | 2023-09-30 | $552,000 | −$174,000 | −23.97% |
| Q2 2023 | 2023-06-30 | $704,000 | −$262,000 | −27.12% |
| Q1 2023 | 2023-03-31 | $234,000 | −$840,000 | −78.21% |
| Q4 2022 | 2022-12-31 | $503,000 | −$298,000 | −37.20% |
| Q3 2022 | 2022-09-30 | $726,000 | $282,000 | +63.51% |
| Q2 2022 | 2022-06-30 | $966,000 | $533,000 | +123.09% |
| Q1 2022 | 2022-03-31 | $1.1M | $399,000 | +59.11% |
| Q4 2021 | 2021-12-31 | $801,000 | $686,000 | +596.52% |
| Q3 2021 | 2021-09-30 | $444,000 | $313,000 | +238.93% |
| Q2 2021 | 2021-06-30 | $433,000 | $215,000 | +98.62% |
| Q1 2021 | 2021-03-31 | $675,000 | $409,000 | +153.76% |
| Q4 2020 | 2020-12-31 | $115,000 | −$244,000 | −67.97% |
| Q3 2020 | 2020-09-30 | $131,000 | $75,000 | +133.93% |
| Q2 2020 | 2020-06-30 | $218,000 | $94,000 | +75.81% |
| Q1 2020 | 2020-03-31 | $266,000 | −$8,000 | −2.92% |
| Q4 2019 | 2019-12-31 | $359,000 | −$2,000 | −0.55% |
| Q3 2019 | 2019-09-30 | $56,000 | −$81,000 | −59.12% |
| Q2 2019 | 2019-06-30 | $124,000 | −$92,000 | −42.59% |
| Q1 2019 | 2019-03-31 | $274,000 | −$23,000 | −7.74% |
| Q4 2018 | 2018-12-31 | $361,000 | — | — |
| Q3 2018 | 2018-09-30 | $137,000 | −$30,000 | −17.96% |
| Q2 2018 | 2018-06-30 | $216,000 | — | — |
| Q1 2018 | 2018-03-31 | $297,000 | — | — |
| Q3 2017 | 2017-09-30 | $167,000 | — | — |
Neuronetics capital expenditures (capex) trends
Over the last five fiscal years, Neuronetics's capital expenditures (capex) increased from $730,000 to $801,000, a change of $71,000. The latest reported quarter, Q2 2026, shows $417,000.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Neuronetics source filings ↗